|
STOK Stoke Therapeutics Inc 1623526 |
| Balance Sheet |
|
Current Assets
|
$366,681,000.00 |
|
Assets
|
$443,277,000.00 |
|
Current Liabilities
|
$40,806,000.00 |
|
Liabilities
|
$48,400,000.00 |
|
Equity
|
$394,877,000.00 |
|
Shares Out
|
62240347.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-60,582,000.00 |
|
Investing Cash Flow
|
$50,694,000.00 |
| Market Analysis |
Market Cap
|
$1,869,700,023.88 |
|
Price
|
$28.70 |
|
BVPS
|
6.34 |
|
PB
|
4.74 |
|
EPS
|
-0.79 |
|
PS
|
81.68 |
|
FCF
|
$-60,935,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.12 |
|
|
2026-05-07 |
-0.79 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view STOK documents filed with the SEC.
STOK Filings
Clear
